Topic: Transactions

Latest content

Q3 2021 saw a software surge in US patent sales

The most recent AST data shows a 12-point jump in transacted assets, as well as continuing strength in healthcare and semiconductors

07 January 2022

How looming patent cliffs are impacting pharma IP strategies

Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.

05 January 2022

What’s ahead for the global IP market in 2022

Predictions from the IAM editorial team on what the next twelve months have in store

03 January 2022

BlackBerry patent sale almost there but still not over the line

“We are literally down to the last few important items now,” says company CEO John Chen on Q3 earnings call

22 December 2021

It’s a big 48 hours for BlackBerry and the patent market in general

The company is due to release its Q3 financials tomorrow, but it is not known whether the touted sale of a portfolio of well over 30,000 individual assets will also be announced

20 December 2021

Chinese appliance maker scores $26 million win with patent bought from Toshiba

Sizeable damage award against top white goods maker Gree vindicates smaller rival’s strategy for playing IP catch-up through transactions

14 December 2021

Revealed: first Chinese target of ZTE's new SEP licensing push

Court documents show that ZTE has filed a patent suit against Tinno Mobile, the Shenzhen-based company that owns French smartphone brand Wiko

08 December 2021

IP leaders weigh in on what makes or breaks a patent pool

From the need for clarity to the problems of self-certification, top practitioners give their prescriptions for making the most of the pool model

07 December 2021

Hyundai – auto’s quiet patent superpower

The automaker and its affiliates are growing their portfolios in technologies that will be critical for developing the car of the future

06 December 2021

CAFC tees up patent fight over multi-billion-dollar Moderna covid revenues

Arbutus Biopharma’s shares soar in anticipation of mRNA jab royalty lawsuit after Federal Circuit ruling

03 December 2021

Get unlimited access to all IAM content